Tekla Other Stockholder Equity vs Other Current Liab Analysis

HQH Stock

USD 18.68 0.25 1.36%

Tekla Healthcare financial indicator trend analysis is much more than just breaking down Tekla Healthcare Inv prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tekla Healthcare Inv is a good investment. Please check the relationship between Tekla Healthcare Other Stockholder Equity and its Other Current Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Other Stockholder Equity vs Other Current Liab

Other Stockholder Equity vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tekla Healthcare Inv Other Stockholder Equity account and Other Current Liab. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Tekla Healthcare's Other Stockholder Equity and Other Current Liab is -0.28. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Tekla Healthcare Investors, assuming nothing else is changed. The correlation between historical values of Tekla Healthcare's Other Stockholder Equity and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Tekla Healthcare Investors are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Other Stockholder Equity i.e., Tekla Healthcare's Other Stockholder Equity and Other Current Liab go up and down completely randomly.

Correlation Coefficient

-0.28

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Stockholder Equity

Other Current Liab

Most indicators from Tekla Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tekla Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

As of now, Tekla Healthcare's Selling General Administrative is decreasing as compared to previous years. The Tekla Healthcare's current Enterprise Value Over EBITDA is estimated to increase to 12.90, while Sales General And Administrative To Revenue is projected to decrease to 0.02.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.0M	1.8M	2.1M	1.9M
Cost Of Revenue	11.3M	10.9M	12.5M	7.3M

Total Operating Expenses Cost Of Revenue

Tekla Healthcare fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Receivables	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Investments	Other Liab	Other Current Assets	Capital Stock	Short Term Investments	Non Current Liabilities Total
Total Assets		0.01	0.35	1.0	0.19	0.07	1.0	-0.95	-0.74	0.18	0.23	0.85	0.27	0.36	0.37	0.23	0.29	0.77	0.15	0.14	0.8	0.79	-0.17	-0.24	0.05	0.11
Other Current Liab	0.01		0.62	-0.01	0.08	-0.35	0.01	-0.01	-0.12	-0.45	0.21	-0.17	-0.28	0.63	0.02	0.21	0.22	0.16	0.58	0.89	0.03	0.12	0.54	0.29	-0.15	0.15
Total Current Liabilities	0.35	0.62		0.33	0.2	0.12	0.35	-0.37	-0.18	-0.03	0.31	0.16	-0.1	1.0	0.31	0.31	0.28	0.16	0.12	0.75	0.11	0.18	0.23	0.15	-0.02	0.44
Total Stockholder Equity	1.0	-0.01	0.33		0.18	0.07	1.0	-0.95	-0.74	0.19	0.23	0.86	0.27	0.34	0.36	0.23	0.29	0.77	0.15	0.12	0.8	0.79	-0.18	-0.25	0.05	0.09
Net Debt	0.19	0.08	0.2	0.18		-0.52	0.19	-0.2	-0.09	-0.49	-0.56	0.22	0.38	0.2	-0.21	-0.56	0.03	0.14	0.11	-0.15	0.18	0.08	-0.44	-0.58	0.34	0.52
Cash	0.07	-0.35	0.12	0.07	-0.52		0.07	-0.07	-0.01	0.75	0.47	0.0	-0.2	0.1	0.23	0.47	-0.21	0.0	-0.33	-0.02	0.02	0.02	0.13	0.38	0.01	0.19
Non Current Assets Total	1.0	0.01	0.35	1.0	0.19	0.07		-0.96	-0.75	0.18	0.23	0.85	0.27	0.36	0.36	0.23	0.29	0.78	0.15	0.14	0.8	0.79	-0.18	-0.25	0.05	0.1
Non Currrent Assets Other	-0.95	-0.01	-0.37	-0.95	-0.2	-0.07	-0.96		0.77	-0.19	-0.25	-0.75	-0.27	-0.38	-0.37	-0.25	-0.3	-0.77	-0.17	-0.17	-0.79	-0.69	0.17	0.24	0.01	-0.12
Other Assets	-0.74	-0.12	-0.18	-0.74	-0.09	-0.01	-0.75	0.77		-0.07	-0.21	-0.74	-0.41	-0.18	-0.34	-0.21	-0.31	-0.9	-0.25	-0.28	-0.9	-0.9	0.24	0.23	-0.12	0.06
Cash And Short Term Investments	0.18	-0.45	-0.03	0.19	-0.49	0.75	0.18	-0.19	-0.07		0.31	0.07	-0.1	-0.02	0.19	0.31	-0.24	0.09	-0.28	-0.11	0.12	0.08	0.1	0.18	-0.33	-0.05
Common Stock Total Equity	0.23	0.21	0.31	0.23	-0.56	0.47	0.23	-0.25	-0.21	0.31		-0.03	-0.62	0.31	0.11	1.0	-0.08	0.22	0.4	0.38	0.15	0.22	0.62	0.85	-0.46	0.22
Common Stock Shares Outstanding	0.85	-0.17	0.16	0.86	0.22	0.0	0.85	-0.75	-0.74	0.07	-0.03		0.56	0.16	0.44	-0.03	0.41	0.63	-0.18	-0.03	0.69	0.84	-0.55	-0.5	0.4	-0.12
Other Stockholder Equity	0.27	-0.28	-0.1	0.27	0.38	-0.2	0.27	-0.27	-0.41	-0.1	-0.62	0.56		-0.1	0.53	-0.62	0.6	0.2	-0.49	-0.17	0.28	0.32	-0.87	-0.86	0.53	-0.31
Total Liab	0.36	0.63	1.0	0.34	0.2	0.1	0.36	-0.38	-0.18	-0.02	0.31	0.16	-0.1		0.31	0.31	0.28	0.16	0.13	0.75	0.1	0.17	0.25	0.14	-0.04	0.42
Total Current Assets	0.37	0.02	0.31	0.36	-0.21	0.23	0.36	-0.37	-0.34	0.19	0.11	0.44	0.53	0.31		0.11	0.89	0.09	-0.43	0.34	0.1	0.28	-0.37	-0.2	0.15	-0.3
Common Stock	0.23	0.21	0.31	0.23	-0.56	0.47	0.23	-0.25	-0.21	0.31	1.0	-0.03	-0.62	0.31	0.11		-0.08	0.22	0.4	0.38	0.15	0.22	0.62	0.85	-0.46	0.22
Net Receivables	0.29	0.22	0.28	0.29	0.03	-0.21	0.29	-0.3	-0.31	-0.24	-0.08	0.41	0.6	0.28	0.89	-0.08		0.06	-0.28	0.37	0.06	0.24	-0.42	-0.34	0.22	-0.33
Net Tangible Assets	0.77	0.16	0.16	0.77	0.14	0.0	0.78	-0.77	-0.9	0.09	0.22	0.63	0.2	0.16	0.09	0.22	0.06		0.48	0.23	0.99	0.86	-0.01	-0.14	-0.07	0.1
Retained Earnings	0.15	0.58	0.12	0.15	0.11	-0.33	0.15	-0.17	-0.25	-0.28	0.4	-0.18	-0.49	0.13	-0.43	0.4	-0.28	0.48		0.34	0.38	0.26	0.66	0.46	-0.53	0.36
Accounts Payable	0.14	0.89	0.75	0.12	-0.15	-0.02	0.14	-0.17	-0.28	-0.11	0.38	-0.03	-0.17	0.75	0.34	0.38	0.37	0.23	0.34		0.11	0.23	0.46	0.31	-0.16	0.04
Long Term Investments	0.8	0.03	0.11	0.8	0.18	0.02	0.8	-0.79	-0.9	0.12	0.15	0.69	0.28	0.1	0.1	0.15	0.06	0.99	0.38	0.11		0.86	-0.12	-0.23	-0.01	0.09
Other Liab	0.79	0.12	0.18	0.79	0.08	0.02	0.79	-0.69	-0.9	0.08	0.22	0.84	0.32	0.17	0.28	0.22	0.24	0.86	0.26	0.23	0.86		-0.19	-0.17	0.17	-0.02
Other Current Assets	-0.17	0.54	0.23	-0.18	-0.44	0.13	-0.18	0.17	0.24	0.1	0.62	-0.55	-0.87	0.25	-0.37	0.62	-0.42	-0.01	0.66	0.46	-0.12	-0.19		0.83	-0.65	0.19
Capital Stock	-0.24	0.29	0.15	-0.25	-0.58	0.38	-0.25	0.24	0.23	0.18	0.85	-0.5	-0.86	0.14	-0.2	0.85	-0.34	-0.14	0.46	0.31	-0.23	-0.17	0.83		-0.54	0.26
Short Term Investments	0.05	-0.15	-0.02	0.05	0.34	0.01	0.05	0.01	-0.12	-0.33	-0.46	0.4	0.53	-0.04	0.15	-0.46	0.22	-0.07	-0.53	-0.16	-0.01	0.17	-0.65	-0.54		-0.05
Non Current Liabilities Total	0.11	0.15	0.44	0.09	0.52	0.19	0.1	-0.12	0.06	-0.05	0.22	-0.12	-0.31	0.42	-0.3	0.22	-0.33	0.1	0.36	0.04	0.09	-0.02	0.19	0.26	-0.05

Click cells to compare fundamentals

Tekla Healthcare Account Relationship Matchups

Tekla Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1B	1.2B	926.3M	932.5M	1.1B	673.0M
Other Current Liab	(31.4K)	4.3M	1.2M	1.1M	1.0M	982.1K
Total Current Liabilities	31.4K	15.6M	9.7M	1.1M	1.3M	1.3M
Total Stockholder Equity	1.1B	1.2B	916.6M	931.3M	1.1B	667.3M
Net Debt	2.5M	11.3M	8.5M	(214.0)	(246.1)	(233.79)
Cash	(2.5M)	935.0	792.0	214.0	192.6	182.97
Non Current Assets Total	1.1B	1.2B	923.4M	925.6M	1.1B	686.0M
Non Currrent Assets Other	(1.1B)	(1.2B)	(923.4M)	(925.6M)	(833.0M)	(874.7M)
Other Assets	264.1K	66.1K	49.4K	51.1K	46.0K	43.7K
Cash And Short Term Investments	2.5M	935.0	792.0	214.0	246.1	233.8
Common Stock Shares Outstanding	43.9M	44.5M	47.3M	49.4M	56.9M	30.4M
Liabilities And Stockholders Equity	1.1B	1.2B	926.3M	932.5M	1.1B	673.0M
Total Liab	1.1M	15.6M	9.7M	1.1M	1.3M	1.3M
Total Current Assets	4.1M	4.0M	2.9M	6.9M	7.9M	8.3M
Common Stock	438.7K	454.3K	473.4K	494.4K	568.6K	540.2K
Net Receivables	4.1M	4.0M	2.9M	6.9M	7.9M	8.3M
Net Tangible Assets	870.8M	1.1B	1.2B	916.6M	1.1B	962.8M
Retained Earnings	239.5M	303.1M	24.8M	6.0M	5.4M	5.1M
Long Term Investments	1.1B	1.2B	923.4M	925.6M	1.1B	954.8M
Other Current Assets	(6.6M)	(23.7M)	(51.2M)	(39.6M)	(35.6M)	(33.9M)
Capital Stock	438.7K	454.3K	473.4K	494.4K	445.0K	422.7K
Short Term Investments	2.5M	19.6M	48.3M	32.7M	37.6M	26.2M
Non Current Liabilities Total	1.1M	15.6M	9.7M	1.1M	1.0M	982.1K

Currently Active Assets on Macroaxis

CRM	Salesforce
CRM	Salesforce
S	SentinelOne
V	Visa Class A
GOOG	Alphabet Inc Class C

When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:

How To Invest In Tekla

Details

Is Tekla Stock a good investment?

Details

What is Tekla Healthcare's Net Worth?

Details

Largest Asset Management & Custody Banks Companies

View

Largest Financial Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.145

Dividend Share

1.66

Earnings Share

1.31

Revenue Per Share

0.197

Quarterly Revenue Growth

(0.06)

The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tekla Other Stockholder Equity vs Other Current Liab Analysis

Other Stockholder Equity vs Other Current Liab

Other Stockholder Equity vs Other Current Liab Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Other Current Liab

Tekla Healthcare fundamental ratios Correlations

Tekla Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tekla Healthcare fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Non Current Assets Total	+ 1.0	Total Stockholder Equity
Common Stock	+ 1.0	Common Stock Total Equity
Long Term Investments	+ 0.99	Net Tangible Assets

Non Currrent Assets Other	- 0.96	Non Current Assets Total
Non Currrent Assets Other	- 0.95	Total Stockholder Equity
Non Currrent Assets Other	- 0.95	Total Assets
Other Liab	- 0.9	Other Assets
Long Term Investments	- 0.9	Other Assets
Net Tangible Assets	- 0.9	Other Assets